rs6582630
|
|
Chemical and Drug Induced Liver Injury
|
|
0.800 |
GeneticVariation
|
GWASDB |
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.
|
19483685 |
2009 |
rs6582630
|
|
Chemical and Drug Induced Liver Injury
|
|
0.800 |
GeneticVariation
|
GWASCAT |
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.
|
19483685 |
2009 |
rs2523822
|
|
Chemical and Drug Induced Liver Injury
|
|
0.800 |
GeneticVariation
|
GWASDB |
Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles.
|
21570397 |
2011 |
rs2523822
|
|
Chemical and Drug Induced Liver Injury
|
|
0.800 |
GeneticVariation
|
GWASCAT |
Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles.
|
21570397 |
2011 |
rs10812428
|
|
Chemical and Drug Induced Liver Injury
|
|
0.800 |
GeneticVariation
|
GWASDB |
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.
|
19483685 |
2009 |
rs10812428
|
|
Chemical and Drug Induced Liver Injury
|
|
0.800 |
GeneticVariation
|
GWASCAT |
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.
|
19483685 |
2009 |
rs72696020
|
|
Chemical and Drug Induced Liver Injury
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.
|
28043905 |
2017 |
rs72631567
|
|
Chemical and Drug Induced Liver Injury
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.
|
28043905 |
2017 |
rs6694270
|
|
Chemical and Drug Induced Liver Injury
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.
|
28043905 |
2017 |
rs61858823
|
|
Chemical and Drug Induced Liver Injury
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.
|
28043905 |
2017 |
rs4842407
|
|
Chemical and Drug Induced Liver Injury
|
C |
0.700 |
GeneticVariation
|
GWASCAT |
Genome-Wide Association and Replication Study of Hepatotoxicity Induced by Antiretrovirals Alone or with Concomitant Anti-Tuberculosis Drugs.
|
28388302 |
2017 |
rs186920977
|
|
Chemical and Drug Induced Liver Injury
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.
|
28043905 |
2017 |
rs1495741
|
|
Chemical and Drug Induced Liver Injury
|
A |
0.700 |
GeneticVariation
|
GWASCAT |
Genomewide Association Study Confirming the Association of NAT2 with Susceptibility to Antituberculosis Drug-Induced Liver Injury in Thai Patients.
|
31109976 |
2019 |
rs149014830
|
|
Chemical and Drug Induced Liver Injury
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.
|
28043905 |
2017 |
rs116606120
|
|
Chemical and Drug Induced Liver Injury
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.
|
28043905 |
2017 |
rs116561224
|
|
Chemical and Drug Induced Liver Injury
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.
|
28043905 |
2017 |
rs114811931
|
|
Chemical and Drug Induced Liver Injury
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.
|
28043905 |
2017 |
rs113206698
|
|
Chemical and Drug Induced Liver Injury
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.
|
28043905 |
2017 |
rs117491755
|
|
Chemical and Drug Induced Liver Injury
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.
|
28043905 |
2017 |
rs10404821
|
|
Chemical and Drug Induced Liver Injury
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.
|
28043905 |
2017 |
rs185305928
|
|
Chemical and Drug Induced Liver Injury
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.
|
28043905 |
2017 |
rs191153876
|
|
Chemical and Drug Induced Liver Injury
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.
|
28043905 |
2017 |
rs2395029
|
|
Chemical and Drug Induced Liver Injury
|
|
0.800 |
GeneticVariation
|
GWASCAT |
Drug-Induced Liver Injury due to Flucloxacillin: Relevance of Multiple Human Leukocyte Antigen Alleles.
|
30661239 |
2019 |
rs2395029
|
|
Chemical and Drug Induced Liver Injury
|
|
0.800 |
GeneticVariation
|
GWASCAT |
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.
|
19483685 |
2009 |
rs2395029
|
|
Chemical and Drug Induced Liver Injury
|
|
0.800 |
GeneticVariation
|
GWASDB |
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.
|
19483685 |
2009 |